The University of Chicago Header Logo

Connection

Michael Becker to Drug Resistance, Neoplasm

This is a "connection" page, showing publications Michael Becker has written about Drug Resistance, Neoplasm.
Connection Strength

0.085
  1. A phase I study of decitabine and rapamycin in relapsed/refractory AML. Leuk Res. 2013 Dec; 37(12):1622-7.
    View in: PubMed
    Score: 0.085
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.